Last reviewed · How we verify
Uriadec (TOPIROXOSTAT)
Uriadec (generic name: TOPIROXOSTAT) is a Small molecule drug developed by Senwa Kegaku Kenkyushp. It is currently FDA-approved for Gout, Hyperuricemia.
At a glance
| Generic name | TOPIROXOSTAT |
|---|---|
| Sponsor | Senwa Kegaku Kenkyushp |
| Target | ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Gout
- Hyperuricemia
Common side effects
Key clinical trials
- Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) (PHASE2)
- Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Uriadec CI brief — competitive landscape report
- Uriadec updates RSS · CI watch RSS
Frequently asked questions about Uriadec
What is Uriadec?
Uriadec (TOPIROXOSTAT) is a Small molecule drug developed by Senwa Kegaku Kenkyushp, indicated for Gout, Hyperuricemia.
What is Uriadec used for?
Uriadec is indicated for Gout, Hyperuricemia.
Who makes Uriadec?
Uriadec is developed and marketed by Senwa Kegaku Kenkyushp.
What is the generic name of Uriadec?
TOPIROXOSTAT is the generic (nonproprietary) name of Uriadec.
What development phase is Uriadec in?
Uriadec is FDA-approved (marketed).
What does Uriadec target?
Uriadec targets ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase.
Related
- Target: All drugs targeting ATP-binding cassette sub-family G member 2, Xanthine dehydrogenase/oxidase, Xanthine dehydrogenase/oxidase
- Therapeutic area: All drugs in Other
- Indication: Drugs for Gout
- Indication: Drugs for Hyperuricemia